Oxford Biomedica PLC 2025 Annual Report with Sustainability Disclosures
Company: Oxford Biomedica PLC
Sector: Professional & technical services
Country: United Kingdom
Year: 2025
Type: Annual Report with Sustainability Disclosures
Pages: 196
The report describes a milestone 2025, with reported revenue of £168.7 million and the acquisition of a commercial-scale viral-vector manufacturing facility in Durham, North Carolina. It highlights a 39.7% cumulative reduction in operational emissions from the 2021 baseline and continued renewable-electricity procurement. The report also states that OXB's near-term emission-reduction targets were validated in April 2025 and that ESG-linked KPIs were incorporated into annual bonus arrangements.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.